New York, NY, United States of America

Megan Fitzpatrick Forrest

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: International Aids Vaccine Initiative. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Megan Fitzpatrick Forrest. Retrieved from https://idiyas.com/inventor/megan-fitzpatrick-forrest

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Megan Fitzpatrick Forrest: Innovator in Tuberculosis Research

Introduction

Megan Fitzpatrick Forrest is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of medical research, particularly in the development of innovative solutions for tuberculosis.

Latest Patents

Megan holds 2 patents related to tuberculosis antigen cassettes. Her latest patents focus on fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding these antigens, and methods for eliciting an immune response against tuberculosis. These advancements are crucial in the ongoing fight against this infectious disease.

Career Highlights

Megan is currently associated with the International Aids Vaccine Initiative, where she applies her expertise to develop vaccines and therapeutic strategies. Her work is instrumental in addressing global health challenges.

Collaborations

Megan collaborates with notable colleagues, including Nathalie Cadieux and Dominick J Laddy, to further her research and innovation in the field.

Conclusion

Megan Fitzpatrick Forrest is a dedicated inventor whose work in tuberculosis research is paving the way for new medical advancements. Her contributions are vital in the quest for effective treatments and vaccines against this disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…